» Articles » PMID: 18243319

Activating KIRs Exert a Crucial Role on Relapse and Overall Survival After HLA-identical Sibling Transplantation

Overview
Journal Mol Immunol
Date 2008 Feb 5
PMID 18243319
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Recognition of HLA-C molecules by killer cell immunoglobulin-like receptors (KIRs) is an important mechanism in the regulation of natural killer (NK) cell activity. Eradication of residual leukaemic cells by alloreactive donor NK cells after haematopoietic stem cell transplantation (HSCT) fulfils a crucial role in the control of relapse. This retrospective study evaluates 83 patients and their related donors. All individuals were typed at low-resolution level to determine their HLA repertoire. KIR genotyping data were obtained by the use of sequence-specific oligonucleotide (SSO) analysis. All data were combined with patient and donor characteristics and post-transplant clinical data. A higher overall survival was seen when KIR2DS1 in the donor was mismatched with the HLA-C group 2 ligand in the patient (p=0.03). The number of activating KIRs either in the patient or in the donor was significantly correlated with the occurrence of relapse (p=0.003 and p=0.02, respectively). In addition, the presence of KIR2DS5 in the patient alone or in both the patient and donor was significantly correlated with the occurrence of relapse (p=0.004 and p=0.005, respectively). In conclusion, significant correlations were found for activating KIRs with overall survival and relapse.

Citing Articles

Decreased iKIR-HLA C Pair Confers Worse Clinical Outcomes for Patients With Myeloid Disease Receiving Antithymocyte Globulin-Based Haploidentical Hematopoietic Stem Cell Transplantation.

Zhao Y, Gao F, Wu Y, Shi J, Luo Y, Tan Y Front Immunol. 2021; 11:614488.

PMID: 33633734 PMC: 7901980. DOI: 10.3389/fimmu.2020.614488.


Influence of KIR and NK Cell Reconstitution in the Outcomes of Hematopoietic Stem Cell Transplantation.

Gao F, Ye Y, Gao Y, Huang H, Zhao Y Front Immunol. 2020; 11:2022.

PMID: 32983145 PMC: 7493622. DOI: 10.3389/fimmu.2020.02022.


Patients Lacking a KIR-Ligand of HLA Group C1 or C2 Have a Better Outcome after Umbilical Cord Blood Transplantation.

Martinez-Losada C, Martin C, Gonzalez R, Manzanares B, Garcia-Torres E, Herrera C Front Immunol. 2017; 8:810.

PMID: 28751893 PMC: 5507950. DOI: 10.3389/fimmu.2017.00810.


Can we make a better match or mismatch with KIR genotyping?.

Mehta R, Rezvani K Hematology Am Soc Hematol Educ Program. 2016; 2016(1):106-118.

PMID: 27913469 PMC: 6142490. DOI: 10.1182/asheducation-2016.1.106.


KIR repertory in patients with hematopoietic diseases and healthy family members.

Sugioka D, Goncalves C, da Graca Bicalho M BMC Hematol. 2016; 16:25.

PMID: 27708784 PMC: 5041293. DOI: 10.1186/s12878-016-0064-6.